Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Adelis in connection with the acquisition of Knightec
Mandate

Vinge advises Adelis in connection with the acquisition of Knightec

May 05, 2017 M&A

Vinge is advising Adelis Equity Partners Fund 1 AB in connection with its acquisition of Knightec whereby Adelis will become the majority owner in Knightec together with founders Dimitris Gioulekas and Håkan Jarnbjer.

The transaction is subject to competition clearance.

Knightec is a consulting firm, which specializes in technology and management for the development of products, systems and production. The company is active primarily in the areas of life science, automotive, transportation, defense, energy and packaging. Since its establishment in 2003, Knightec has grown significantly and today employs over 500 consultants with revenues of SEK 500m.

Vinge’s team consists of responsible partner Jonas Johansson together with amongst others associates Filip Öhrner, Michaela Cronemyr, Anna Thoms, Johan Wahlbom and Siri Dunér. Partner Albert Wållgren and associate Josefine Lanker advises on acquisition financing issues.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025